Drugmakers, including Gilead Sciences Inc, Bristol-Myers Squibb Co, and Biogen Inc have hiked their U.S. list prices on more than 50 drugs, according to data analyzed by 3 Axis Advisors, a healthcare research firm. On Tuesday, there were media reports… Read More ›
France-based pharmaceutical giant, Sanofi SA needs to clinch this deal.The MNC has also obtained the rights to develop and sell a new hemophilia drug in a strategic restructuring of its partnership with Alnylam Pharmaceuticals. As per a report by the… Read More ›
manageria.biz 